sectors
Daily curated global finance headlines in this column. 500 articles.
Free global finance digest · Premium delivery for the best picks
Daily overseas finance news in-app; members get curated thesis, variables, and trade logic via email/SMS before the open.
Aytu BioPharma Q3 2027 Earnings Preview. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this develo…
Meridian Intelligence View: Meridian Intelligence view: Earnings and buybacks reflect past capital allocation. Subjective value differs by individual; markets discover prices continuously—do not equate earnings beats with lasting productivity gains.
Read full article →Dare Bioscience Q3 2026 Earnings Preview. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this devel…
Meridian Intelligence View: Meridian Intelligence view: Earnings and buybacks reflect past capital allocation. Subjective value differs by individual; markets discover prices continuously—do not equate earnings beats with lasting productivity gains.
Read full article →Plus Therapeutics GAAP EPS of -$1.14, revenue of $0.72M. Market participants are assessing the implications for related sectors and asset prices. Analysts note …
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →TRex Bio, Inc. reports Q3 results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this development …
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →AstraZeneca gains additional bladder cancer indication for Imfinzi. Market participants are assessing the implications for related sectors and asset prices. Ana…
Meridian Intelligence View: Meridian Intelligence view: The AI boom is entrepreneurial action chasing marginal returns from new tech. Capital inflows inflate valuations; only services consumers willingly pay for represent genuine productivity progress.
Read full article →Femasys GAAP EPS of -$0.53 beats by $0.07, revenue of $0.4M misses by $0.22M. Market participants are assessing the implications for related sectors and asset p…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Enveric Biosciences GAAP EPS of -$0.57. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this develop…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Measles cases rise to over 5,400 across US. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this dev…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →TuHURA Biosciences reports Q3 results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this developm…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Akari Therapeutics reports Q3 results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this developm…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →VolitionRx targets operating cash burn below $1M per month in 2027 as it pushes France sepsis rollout. Market participants are assessing the implications for re…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →DiaMedica expects cash to fund operations into Q4 2027 as ReMEDy2 interim analysis approaches in Q1 2027. Market participants are assessing the implications for…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Planet 13 Holdings GAAP EPS of -$0.02 misses by $0.01, revenue of $23.08M beats by $0.1M. Market participants are assessing the implications for related sectors…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Azitra GAAP EPS of -$0.29 misses by $0.04. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this deve…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Zhengye Biotechnology GAAP EPS of -$0.06, revenue of $7.51M. Market participants are assessing the implications for related sectors and asset prices. Analysts n…
Meridian Intelligence View: Meridian Intelligence view: The AI boom is entrepreneurial action chasing marginal returns from new tech. Capital inflows inflate valuations; only services consumers willingly pay for represent genuine productivity progress.
Read full article →Stevanato Group Non-GAAP EPS of €0.16, revenue of €326.1M. Market participants are assessing the implications for related sectors and asset prices…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Quantum BioPharma Non-GAAP EPS of -$0.06. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this devel…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Serina Therapeutics GAAP EPS of -$0.31 beats by $0.03, revenue of $0.13M. Market participants are assessing the implications for related sectors and asset price…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Appili Therapeutics Inc. reports 1H results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this de…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →SBC outlines longevity revenue contribution around 2028 while signaling further EBITDA margin expansion. Market participants are assessing the implications for …
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Xenetic Biosciences GAAP EPS of -$0.72, revenue of $0.7M. Market participants are assessing the implications for related sectors and asset prices. Analysts note…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Lifeward GAAP EPS of -$1.32 misses by $0.50, revenue of $5.43M misses by $1.81M. Market participants are assessing the implications for related sectors and asse…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →PharmaCyte Biotech GAAP EPS of -$0.54. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this developm…
Meridian Intelligence View: Meridian Intelligence view: The AI boom is entrepreneurial action chasing marginal returns from new tech. Capital inflows inflate valuations; only services consumers willingly pay for represent genuine productivity progress.
Read full article →PAVmed outlines early 2027 Veris 510(k) submission while Lucid secures Medicare reimbursement for EsoGuard. Market participants are assessing the implications f…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Biofrontera GAAP EPS of -$0.42 misses by $0.20, revenue of $9.07M beats by $0.82M. Market participants are assessing the implications for related sectors and as…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Fortress Biotech GAAP EPS of -$0.23 beats by $0.04, revenue of $19.16M misses by $2.41M. Market participants are assessing the implications for related sectors …
Meridian Intelligence View: Meridian Intelligence view: The AI boom is entrepreneurial action chasing marginal returns from new tech. Capital inflows inflate valuations; only services consumers willingly pay for represent genuine productivity progress.
Read full article →Owlet beats top-line and bottom-line estimates; withdrawas 2026 financial outlook. Market participants are assessing the implications for related sectors and as…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →PAVmed Non-GAAP EPS of -$0.19 beats by $0.47. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this d…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Annovis Bio GAAP EPS of -$0.22 beats by $0.08. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this …
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Sienna Senior Living reports Q3 results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this develo…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Electra Therapeutics Q3 GAAP EPS of $3.47 beats by $4.44. Market participants are assessing the implications for related sectors and asset prices. Analysts note…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Milestone Pharmaceuticals GAAP EPS of -$0.18 beats by $0.04, revenue of $2.96M beats by $1.96M. Market participants are assessing the implications for related s…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Tvardi Therapeutics GAAP EPS of -$0.48 beats by $0.01. Market participants are assessing the implications for related sectors and asset prices. Analysts note th…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Generate Biomedicines, Inc. reports Q3 results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that this…
Meridian Intelligence View: Meridian Intelligence view: Rate and jobs data often justify intervention, yet credit expansion drives cycles. Focus on money supply and real savings shaping the capital structure, not central bank rhetoric.
Read full article →Zealand Pharma GAAP EPS of -DKK 0.79, revenue of DKK 4M; updates FY2026 outlook. Market participants are assessing the implications for related sectors and asse…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Park Dental Partners, Inc. Non-GAAP EPS of $0.57 beats by $0.27, revenue of $64.9M beats by $0.29M. Market participants are assessing the implications for relat…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →BlossomHill Therapeutics, Inc. reports Q3 results. Market participants are assessing the implications for related sectors and asset prices. Analysts note that t…
Meridian Intelligence View: Meridian Intelligence view: Headlines show markets repricing information. Prices embed expectations—avoid chasing moves; focus on how individual actors coordinate supply amid dispersed knowledge, not a single macro story.
Read full article →Disclaimer
Auto-fetched and translated global finance news for research only. Not investment advice.